Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University
SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown promise in reducing the risk of atrial fibrillation (AF). However, the results are controversial and the underlying metabolic mechanism remains uncl...